Pfizer won't sell drugs for profit in poor nations

Pfizer mentioned Wednesday that it'll present practically two dozen merchandise, together with its top-selling COVID-19 vaccine and remedy, at not-for-profit costs in a few of the world's poorest international locations.


The drugmaker introduced this system on the World Financial Discussion board's annual gathering in Davos, Switzerland, and mentioned it was aimed toward enhancing well being fairness in 45 lower-income international locations. A lot of the international locations are in Africa, however the checklist additionally consists of Haiti, Syria, Cambodia and North Korea.


The merchandise, that are extensively out there within the U.S. and the European Union, embrace 23 medicines and vaccines that deal with infectious ailments, some cancers and uncommon and inflammatory situations. Firm spokeswoman Pam Eisele mentioned solely a small variety of the medicines and vaccines are presently out there within the 45 international locations.


New York-based Pfizer will cost solely manufacturing prices and "minimal" distribution bills, Eisele mentioned. It is going to adjust to any sanctions and all different relevant legal guidelines.


The drugmaker additionally plans to offer assist with public schooling, coaching for well being care suppliers and drug provide administration.


"What we found via the pandemic was that provide was not sufficient to resolve the problems that these international locations are having," Pfizer Chairman and CEO Albert Bourla mentioned Wednesday throughout a chat at Davos.


He famous that billions of doses of the corporate's COVID-19 vaccine, Comirnaty, have been supplied at no cost to low-income international locations, primarily via the U.S. authorities, however these doses cannot be used proper now.


Earlier this month, the top of the World Well being Group referred to as on Pfizer to make its COVID-19 remedy extra extensively out there in poorer international locations.


Comirnaty introduced in practically $37 billion in gross sales final yr, and analysts count on the corporate's COVID-19 remedy Paxlovid so as to add virtually $24 billion this yr, based on the information agency FactSet.

------

The Related Press Well being and Science Division receives assist from the Howard Hughes Medical Institute's Division of Science Schooling. The AP is solely accountable for all content material

Post a Comment

Previous Post Next Post